Search Results - "Repsilber D"

This result is not displayed to guests.
Login for full access.

Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.

Authors: Jacobsen, M. Repsilber, D. Kleinsteuber, K. et al.

Source: Clinical Microbiology & Infection. Sep2011, Vol. 17 Issue 9, p1323-1331. 9p.

Human gene expression profiles of susceptibility and resistance in tuberculosis.

Authors: Maertzdorf, J Repsilber, D Parida, S K et al.

Source: Genes & Immunity. Jan2011, Vol. 12 Issue 1, p15-22. 8p. 1 Diagram, 4 Charts, 2 Graphs.

Time-lapse image analysis reveals trigger-dependent differences in ASC speck lifetime in the NLRP3 inflammasome.

Authors: Herring, M. Persson, A. Karlsson, R. et al.

Source: Scientific Reports. 5/4/2026, Vol. 16 Issue 1, p1-13. 13p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The exposome metabolome in paediatric inflammatory bowel disease: A cross-sectional study in a population-based Norwegian cohort.

Authors: Salomon, B. Salihovic, S. Bache-Wiig Mathisen, C. et al.

Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi603-i605. 3p.

Preclinical Anti-Integrin αvβ6 Autoantibodies in Ulcerative Colitis: Validation of Predictive Performance, Early Life Emergence and Environmental Modifiers across Multiple Population-Based Cohorts.

Authors: Pertsinidou, E. Grännö, O. Bergemalm, D. et al.

Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi76-i78. 3p.

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.

Authors: Kalla, R Adams, A T Bergemalm, D et al.

Source: Journal of Crohn's & Colitis. May2021, Vol. 15 Issue 5, p699-708. 10p.

NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD.

Authors: Bergemalm, D. Füchtbauer, D. Rejller, M. et al.

Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi8-i9. 2p.

Objectively measuring behaviour traits in an automated restraint-test for ungulates: towards making temperament measurable.

Authors: GRAUNKE, K. L. LANGBEIN, J. REPSILBER, D. et al.

Source: Journal of Agricultural Science. Feb2013, Vol. 151 Issue 1, p141-149. 9p.

The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.

Authors: Rangel, I. Sundin, J. Fuentes, S. et al.

Source: Alimentary Pharmacology & Therapeutics. Nov2015, Vol. 42 Issue 10, p1211-1221. 11p. 2 Charts, 4 Graphs.

OS02-05 Particulate matter emitted in post-processing of additively manufactured metallic alloys induces acute inflammatory responses in human macrophages: a multi-omics approach.

Authors: Alijagic, A. Hyötyläinen, T. Andersson, L. et al.

Source: Toxicology Letters. 2025 Supplement, Vol. 411, pS56-S56. 1p.

OS03-08 Comprehensive chemical and toxicological screening of e-waste plastic chemicals.

Authors: Alijagic, A. Seilitz, F. Södergren Bredberg, A. et al.

Source: Toxicology Letters. 2024 Supplement 2, Vol. 399, pS66-S66. 1p.